BOK Financial Private Wealth’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$240K Sell
3,820
-394
-9% -$31.5K 0.01% 168
2025
Q4
$402K Buy
4,214
+246
+6% +$24.1K 0.02% 141
2025
Q3
$387K Buy
3,968
+3,599
+975% +$373K 0.02% 137
2025
Q2
$39.6K Hold
369
﹤0.01% 262
2025
Q1
$37.2K Sell
369
-28
-7% -$2.82K ﹤0.01% 284
2024
Q4
$35.5K Buy
397
+28
+8% +$2.46K ﹤0.01% 290
2024
Q3
$30.9K Hold
369
﹤0.01% 309
2024
Q2
$28.4K Hold
369
﹤0.01% 315
2024
Q1
$25.3K Sell
369
-369
-50% -$23.7K ﹤0.01% 314
2023
Q4
$42.7K Hold
738
﹤0.01% 261
2023
Q3
$39K Buy
+738
New +$38.7K ﹤0.01% 246
2022
Q2
Sell
-5,885
Closed -$261K 379
2022
Q1
$261K Buy
+5,885
New +$255K 0.02% 257

Other funds holding BSX

BOK Financial Private Wealth's BSX Position: Q1 2026 in Review

BOK Financial Private Wealth reduced its Boston Scientific (BSX) stake by 9.3% in Q1 2026, selling an estimated $31.5K and leaving 3,820 shares worth $240K. The position accounts for 0.01% of the portfolio, ranked #168.

BOK Financial Private Wealth first reported a position in BSX in Q1 2022 and has held it in 12 quarters since. The position peaked at $402K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • BOK Financial Private Wealth held 3,820 shares of Boston Scientific worth $240K as of Q1 2026.
  • BOK Financial Private Wealth sold 394 Boston Scientific shares in Q1 2026, an estimated $31.5K.
  • Boston Scientific made up 0.01% of BOK Financial Private Wealth's portfolio in Q1 2026, its #168 holding.
  • BOK Financial Private Wealth first reported a position in Boston Scientific in Q1 2022 and has held it in 12 quarters since.
  • BOK Financial Private Wealth's Boston Scientific position peaked at $402K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on BOK Financial Private Wealth's 13F filing for Q1 2026, filed 12 May 2026.